drugset / Trial / NCT05905653
Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the safety and plasma pharmacokinetics of STN1012600 ophthalmic solution 0.002% (1 drop once daily for 7 days) in healthy adult male subjects.
Timeline
- Start
- 2023-05-25
- Primary completion
- 2023-06-21
- Completion
- 2023-06-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sepetaprost | Small molecule | 0.002 % | Other |
Indications
No indication recorded.